Cutting Edge of Transplantation
February 8-10, 2018
Arizona Biltmore - Phoenix, AZ
The educational design of this activity addresses the needs of healthcare professionals (physicians, surgeons, pharmacists, nurses, and others) and researchers working in the field of transplantation.
Statement of Need/Program Overview
As the organ shortage has become more severe, ideal requirements for selection of organ donors are far from feasible. Organs that previously would have been considered unsuitable for transplantation, are, with advances in technology, now being used. This new class of organ donor, the “marginal” donor, may include older donors, those with chronic disease, or in selected cases those with infectious diseases. CEOT approaches the topic of marginal organs to increase the organ pool by reviewing administrative strategies to encourage centers to use marginal organs, sharing best practices to safely use marginal organs, and exploring interventions in the deceased organ donor to improve organ quality as well as optimal strategies to repair organs ex-vivo.
The following overarching objectives and more specific goals have been identified for this meeting. Having participated in this meeting, attendees will be able to:
Understand the regulatory and public policy practices that currently govern the practice of organ transplantation and how they impact, and in some cases limit the practice of transplantation.
Understand the diverse perspectives on the purposes and value of regulatory measures in transplantation as a tool to assure the integrity and safety of the national organ donation and transplantation system while at the same time potentially limiting flexibility and adaptation.
More specifically attendees with be able to:
Describe the conflicting metrics by which the performance of Organ Procurement Organizations and Transplant Centers is evaluated and how this potentially limits transplantation.
Describe how the current focus of Program Specific Reports on one year outcomes limits the development and implantation of practices that would potentially lead to improved long-term outcomes.
Describe how the current endpoints used for the approval of new therapeutic agents in transplantation may discourage the development of new immunosuppressive agents.
Describe how the policies and practices governing organ donation, procurement, and allocation may be limiting the number and quality of organs available for transplantation.
Describe how existing regulations and policies impact the utilization of mechanical support devices and their integration into the practice of transplanting thoracic organs.
Continuing Education Credit
This activity is jointly provided by Global Education Group and American Society of Transplantation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and American Society of Transplantation. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this live activity for up to 12.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for up to 12.5 contact hour(s) (12.5 CEUs) of the Accreditation Council for Pharmacy Education. Each approved session will have its own UAN identification number (UANs pending).
This is a knowledge-based activity.
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
This educational activity for up to 12.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or CME@globaleducationgroup.com.
How to Claim Credit
Following the meeting, attendees must complete an online evaluation form in order to request a certificate for any of the types of credit listed above, or for a general certificate of attendance.
Fee Information & Refund/Cancellation Policy
AST Doctoral Member - $340.00
AST Non-Doctoral Member - $210.00
AST Trainee Member - $195.00
Doctoral Non-Member - $895.00
Non-Doctoal Non-Member - $260.00
Trainee Non-Member - $335.00
Industry (Non-Member, Doctoral, or Non-Doctoral) - $895.00
*To cancel your registration, a written request must be received in the AST office by January 5th, 2018. Cancellation requests received by this date will be refunded less a $50 processing fee per person. Requests will be processed after the meeting. There will be no refunds issued for requests received on or after the above date.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. An information packet will be available that contains the faculty conflict of interest disclosures and other important information.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and American Society of Transplantation do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.